Loss of expression of miR-335 is implicated in hepatic stellate cell migration and activation.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Experimental Cell Research

• Publication date

  2011-07-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.yexcr.2011.05.001PMID 21586285
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Micro‐RNA profiling reveals a role for miR‐29 in human and murine liver fibrosis

  2011cited by this paper
• Suppression of type I collagen production by microRNA-29b in cultured human stellate cells.

  2010cited by this paper
• Liver fibrosis causes downregulation of miRNA-150 and miRNA-194 in hepatic stellate cells, and their overexpression causes decreased stellate cell activation.

  2010cited by this paper
• Effects of upregulated expression of microRNA-16 on biological properties of culture-activated hepatic stellate cells

  2009cited by this paper
• Over‐expressed microRNA‐27a and 27b influence fat accumulation and cell proliferation during rat hepatic stellate cell activation

  2009cited by this paper
• miR-15b and miR-16 are implicated in activation of the rat hepatic stellate cell: An essential role for apoptosis.

  2009cited by this paper
• Tenascin expression in human chronic liver disease and in hepatocellular carcinoma.

  2008cited by this paper
• Endogenous human microRNAs that suppress breast cancer metastasis

  2008cited by this paper
• Recent advances in the pathogenesis and diagnosis of liver fibrosis

  2008cited by this paper
• Target mimics modulate miRNAs

  2007cited by this paper
• Deficiency of tenascin‐C attenuates liver fibrosis in immune‐mediated chronic hepatitis in mice

  2007cited by this paper
• Tenascin-C regulates proliferation and migration of cultured astrocytes in a scratch wound assay.

  2005cited by this paper
• Vascular endothelial growth factor and receptor interaction is a prerequisite for murine hepatic fibrogenesis

  2003cited by this paper
• Liver fibrosis: insights into migration of hepatic stellate cells in response to extracellular matrix and growth factors.

  2003cited by this paper
• Rho and p38 MAP kinase signaling pathways mediate LPA-stimulated hepatic myofibroblast migration.

  2003cited by this paper
• Nitrovasodilators inhibit platelet-derived growth factor-induced proliferation and migration of activated human hepatic stellate cells.

  2000cited by this paper
• PDGF-Mediated Chemoattraction of Hepatic Stellate Cells by Bile Duct Segments in Cholestatic Liver Injury

  2000cited by this paper
• Hypoxic stimulation of vascular endothelial growth factor expression in activated rat hepatic stellate cells

  2000cited by this paper
• Rat liver myofibroblasts and hepatic stellate cells: different cell populations of the fibroblast lineage with fibrogenic potential.

  1999cited by this paper
• In Vitro Migratory potential of rat quiescent hepatic stellate cells and its augmentation by cell activation

  1999cited by this paper
• Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing.

  1998cited by this paper
• Focal adhesion kinase and phospholipase C gamma involvement in adhesion and migration of human hepatic stellate cells.

  1997cited by this paper
• Astrogliosis in culture: I. The model and the effect of antisense oligonucleotides on glial fibrillary acidic protein synthesis

  1993cited by this paper
• Expression of the novel extracellular matrix component tenascin in normal and diseased human liver. An immunohistochemical study.

  1990cited by this paper
• Isolation and culture of hepatic lipocytes, Kupffer cells, and sinusoidal endothelial cells by density gradient centrifugation with Stractan.

  1987cited by this paper
• Early alcoholic liver injury. Activation of lipocytes in acinar zone 3 and correlation to degree of collagen formation in the Disse space.

  1986cited by this paper

• MicroRNA dynamics and networks to liver fibrosis-related genes during hepatic stellate cell activation by agalactosyl IgG and transforming growth factor-β1.

  2025cites this paper
• miR-200-mediated inactivation of cancer-associated fibroblasts via targeting of NRP2-VEGFR signaling attenuates lung cancer invasion and metastasis

  2024cites this paper
• Exosomal delivery of TRAIL and miR-335 for the treatment of hepatocellular carcinoma (Review)

  2022cites this paper
• Roles of microRNAs in Hepatitis C Virus Replication and Pathogenesis

  2022cites this paper
• Liver Regeneration: Changes in Oxidative Stress, Immune System, Cytokines, and Epigenetic Modifications Associated with Aging

  2022cites this paper
• Human umbilical cord mesenchymal stem cell-derived exosomal miR-335-5p attenuates the inflammation and tubular epithelial–myofibroblast transdifferentiation of renal tubular epithelial cells by reducing ADAM19 protein levels

  2022cites this paper
• Clinical impact of serum exosomal microRNA in liver fibrosis

  2021cites this paper
• Inhibition of miR‐188‐5p alleviates hepatic fibrosis by significantly reducing the activation and proliferation of HSCs through PTEN/PI3K/AKT pathway

  2021cites this paper
• Noncoding RNAs Interactions in Hepatic Stellate Cells during Hepatic Fibrosis

  2021cites this paper
• Non-alcoholic Steatohepatitis Pathogenesis, Diagnosis, and Treatment

  2021cites this paper
• miR-98-5p as a novel biomarker suppress liver fibrosis by targeting TGFβ receptor 1

  2021influential citation
• HCV Proteins Modulate the Host Cell miRNA Expression Contributing to Hepatitis C Pathogenesis and Hepatocellular Carcinoma Development

  2021cites this paper
• MicroRNA Interference in Hepatic Host-Pathogen Interactions

  2021cites this paper
• Research Trends in the Efficacy of Stem Cell Therapy for Hepatic Diseases Based on MicroRNA Profiling

  2020cites this paper
• Title Intrahepatic MicroRNA Profile of Liver Transplant Recipients withHepatitis C Virus Co-Infected with Human Immunodeficiency Virus

  2019cites this paper
• Epigenetic modulation of tenascin C in the heart: implications on myocardial ischemia, hypertrophy and metabolism.

  2019cites this paper
• Mechanism of Fibrosis Induced by Echinococcus spp.

  2019cites this paper
• Upregulation of microRNA‐9‐5p inhibits apoptosis of chondrocytes through downregulating Tnc in mice with osteoarthritis following tibial plateau fracture

  2019cites this paper
• Antifibrotic Potential of MiR-335-3p in Hereditary Gingival Fibromatosis

  2019cites this paper
• lncRNA GAS5 restrains CCl4-induced hepatic fibrosis by targeting miR-23a through the PTEN/PI3K/Akt signaling pathway.

  2019cites this paper
• Exosome miR‐335 as a novel therapeutic strategy in hepatocellular carcinoma

  2018cites this paper
• Exosomal microRNAs as a potential therapeutic strategy in hepatocellular carcinoma

  2018cites this paper
• Identification and characterization of microRNAs in the pituitary of pubescent goats

  2018cites this paper
• The Role of microRNAs in the Gut-Liver Axis

  2018cites this paper
• Oxidative stress is bane in chronic liver diseases: Clinical and experimental perspective.

  2018cites this paper
• MicroRNA‐335‐5p suppresses lower extremity deep venous thrombosis by targeted inhibition of PAI‐1 via the TLR4 signalingpathway

  2018cites this paper
• Epigenetics and pathogenesis of systemic sclerosis; the ins and outs.

  2018cites this paper
• MicroRNAs as noninvasive biomarkers for the diagnosis and prognosis of liver fibrosis in HCV genotype 4 patients

  2018cites this paper
• Upregulation of microRNA‐335‐5p reduces inflammatory responses by inhibiting FASN through the activation of AMPK/ULK1 signaling pathway in a septic mouse model

  2018cites this paper
• MicroRNA-125b Promotes Hepatic Stellate Cell Activation and Liver Fibrosis by Activating RhoA Signaling

  2018cites this paper
• Molecular interplays in hepatic stellate cells: apoptosis, senescence, and phenotype reversion as cellular connections that modulate liver fibrosis

  2017cites this paper
• Intrahepatic MicroRNA Profile of Liver Transplant Recipients with Hepatitis C Virus Co-Infected with Human Immunodeficiency Virus

  2017cites this paper
• Epigenetics and Liver Fibrosis

  2017cites this paper
• Dysregulation of miRNA Expression in Cancer Associated Fibroblasts (CAFs) and Its Consequences on the Tumor Microenvironment

  2017cites this paper
• The effect of the hepatitis C virus (HCV) NS3 protein on the expression of miR-150, miR-199a, miR-335, miR-194 and miR-27a.

  2017cites this paper
• miRNA-338-3p/CDK4 signaling pathway suppressed hepatic stellate cell activation and proliferation

  2017cites this paper
• Effect of TGF-β/smad signaling pathway blocking on expression profiles of miR-335, miR-150, miR-194, miR-27a, and miR-199a of hepatic stellate cells (HSCs)

  2017cites this paper
• MicroRNA signature in the chemoprevention of functionally-enriched stem and progenitor pools (FESPP) by Active Hexose Correlated Compound (AHCC)

  2017cites this paper
• Tenascin C in colorectal cancer stroma is a predictive marker for liver metastasis and is a potent target of miR-198 as identified by microRNA analysis

  2017cites this paper
• MicroRNAs in the Communication between Cancer Associated Fibroblasts (CAF) and Cancer Cells

  2017cites this paper
• Dysregulation of hepatic microRNA expression profiles with Clonorchis sinensis infection

  2016cites this paper
• Epigenetic regulation of hepatic stellate cell activation and liver fibrosis

  2016cites this paper
• The WNT signalling pathway in systemic sclerosis

  2016cites this paper
• Mechanistically linked serum miRNAs distinguish between drug induced and fatty liver disease of different grades

  2016cites this paper
• The role of microRNAs in the pathogenesis of autoimmune diseases.

  2016cites this paper
• MicroRNA signature in the chemoprevention of breast cancer stem cells by Active Hexose Correlated Compound (AHCC)

  2016cites this paper
• Polymeric Nanocarriers for Delivery of Small Molecules and miRNAs for the Treatment of Liver Fibrosis and Pancreatic Cancer

  2016cites this paper
• Epigenetic regulation of hepatic stellate cell activation and liver fibrosis.

  2016cites this paper
• Poor Nutrition Leading to Potential Clinically Relevant Pathologies: The Role of Epigenetics and Myostatin Signalling

  2016cites this paper
• Modeling pulmonary fibrosis by AAV-mediated TGFβ1 Expression : a proof of concept study for AAV-based disease modeling and riboswitch-controlled vector production

  2016cites this paper
• Hydatid cyst fluid promotes peri-cystic fibrosis in cystic echinococcosis by suppressing miR-19 expression

  2016cites this paper
• Loss-of-function screening to identify miRNAs involved in senescence: tumor suppressor activity of miRNA-335 and its new target CARF

  2016cites this paper
• Hepatic Stellate Cells and microRNAs in Pathogenesis of Liver Fibrosis

  2016influential citation
• Co-delivery of small molecule hedgehog inhibitor and miRNA for treating liver fibrosis.

  2016cites this paper
• Reversibility and heritability of liver fibrosis: Implications for research and therapy.

  2015cites this paper
• Erratum to: RNA sequencing reveals a depletion of collagen targeting microRNAs in Dupuytren’s disease

  2015cites this paper
• Epigenetic Modifications in Fibrotic Diseases: Implications for Pathogenesis and Pharmacological Targets

  2015cites this paper
• The role of miRNAs in the regulation of inflammatory processes during hepatofibrogenesis.

  2015cites this paper
• MicroRNAs in Fatty Liver Disease

  2015cites this paper
• MiR-9a-5p regulates proliferation and migration of hepatic stellate cells under pressure through inhibition of Sirt1.

  2015cites this paper
• Inhibition of microRNA-214 ameliorates hepatic fibrosis and tumor incidence in platelet-derived growth factor C transgenic mice

  2015cites this paper
• RNA sequencing reveals a depletion of collagen targeting microRNAs in Dupuytren’s disease

  2015cites this paper
• MicroRNA Expression Relating to Dietary-Induced Liver Steatosis and NASH

  2015cites this paper
• Functional and diagnostic role of microRNAs in Schistosoma mansoni infection

  2015influential citation
• The role of miRNAs in stress-responsive hepatic stellate cells during liver fibrosis

  2015cites this paper
• The role of the miR-31/FIH1 pathway in TGF-β-induced liver fibrosis.

  2015cites this paper
• Hepatic microRNA orchestra: a new diagnostic, prognostic and theranostic tool for hepatocarcinogenesis.

  2014cites this paper
• MicroRNA-dependent targeting of the extracellular matrix as a mechanism of regulating cell behavior.

  2014cites this paper
• Expression of microRNA-454 in TGF-β1-stimulated hepatic stellate cells and in mouse livers infected with Schistosoma japonicum

  2014cites this paper
• Therapeutic Potential of MicroRNA: A New Target to Treat Intrahepatic Portal Hypertension?

  2014cites this paper
• Delivery and Targeting of miRNAs for Treating Liver Fibrosis

  2014cites this paper
• Overexpression of miR-126 Inhibits the Activation and Migration of HSCs through Targeting CRK

  2014cites this paper
• Participation of miR-200a in TGF-β1-mediated hepatic stellate cell activation

  2014cites this paper
• Membrane-to-Nucleus Signals and Epigenetic Mechanisms for Myofibroblastic Activation and Desmoplastic Stroma: Potential Therapeutic Targets for Liver Metastasis?

  2014cites this paper
• MicroRNA in hepatic fibrosis and cirrhosis.

  2014cites this paper
• Alteration of the microRNA expression profile during the activation of pancreatic stellate cells

  2014influential citation
• MicroRNA in hepatic fibrosis and cirrhosis 1419 causing blood flow changes and the potential development of liver failure

  2014cites this paper
• Gene Therapy for Liver Fibrosis

  2014cites this paper
• MicroRNAs: the fine modulators of liver development and function

  2014cites this paper
• MicroRNAs: the finemodulators of liver development and function

  2014cites this paper
• The role of p19 C-H-Ras protein in metastasis and proliferative pathways

  2013cites this paper
• [Not Available].

  2013cites this paper
• Involvement of microRNA-335-5p in cytoskeleton dynamics in mouse oocytes.

  2013cites this paper
• Dys-Regulated miRNAs in Activated Hepatic Stellate Cells Reported

  2013cites this paper
• Epigenetic regulation of wound healing and fibrosis

  2013cites this paper
• MicroRNAs: their involvement in fibrosis pathogenesis and use as diagnostic biomarkers in scleroderma

  2013cites this paper
• Influence of age on wound healing and fibrosis

  2013cites this paper
• Dual Role of MicroRNAs in NAFLD

  2013cites this paper
• Disparate profiles of dys‐regulated miRNAs in activated hepatic stellate cells

  2013cites this paper
• MicroRNAs, transforming growth factor beta‐1, and tissue fibrosis

  2013cites this paper
• miR-335 promotes cell proliferation by directly targeting Rb1 in meningiomas

  2012cites this paper
• microRNA are Central Players in Anti- and Profibrotic Gene Regulation during Liver Fibrosis

  2012cites this paper
• A New Strategy for Treatment of Liver Fibrosis

  2012cites this paper
• Role of MicroRNAs in Fibrosis

  2012cites this paper
• Expression of platelet-derived growth factor-C and insulin-like growth factor I in hepatic stellate cells is inhibited by miR-29

  2012cites this paper
• Tenascin-C in Cardiovascular Tissue Remodeling

  2012cites this paper
• The potential of microRNAs in liver fibrosis.

  2012cites this paper
• Regulation of breast cancer tumorigenesis and metastasis by miRNAs

  2012cites this paper
• Tenascin-C in cardiovascular tissue remodeling: from development to inflammation and repair.

  2012cites this paper
• MicroRNA-146a modulates TGF-beta1-induced hepatic stellate cell proliferation by targeting SMAD4.

  2012cites this paper